Table 2.

Alzheimer’s disease-associated deregulation of microRNAs targeting FERMT2 and NUP160

Gene	miRNA	AD	References
FERMT2	hsa-miR-29b-3p	Downregulated	Cogswell et al. [32], Hebert et al. [33], Nunez-Iglesias et al. [48], Geekiyanage et al. [49], Hebert et al. [35], Kiko et al. [50], Leidinger et al. [37], Tan et al. [51], Villa et al. [52], Denk et al. [34]
	hsa-miR-107	Downregulated	Hebert et al. [33], Wang et al. [53], Leidinger et al. [37], Muller et al. [54]
	hsa-miR-15a-5p	Downregulated	Cogswell et al. [32], Hebert et al. [33], Nunez-Iglesias et al. [46], Leidinger et al. [37], Denk et al. [34]
	hsa-miR-144-5p	Downregulated	Leidinger et al. [37], Denk et al. [34]
	hsa-miR-103a-3p	Downregulated	Cogswell et al. [32], Hebert et al. [33], Hebert et al. [35], Leidinger et al. [37], Denk et al. [34]
	hsa-miR-582-3p	Downregulated	Hebert et al. [35]
	hsa-miR-498	Not Altered	Hebert et al. [33]
	hsa-miR-29a-5p	Not Altered	Hebert et al. [35], Denk et al. [34]
	hsa-miR-222-3p	Not Altered	Hebert et al. [33], Lau et al. [38], Denk et al. [34]
	hsa-miR-424-5p	Upregulated	Cogswell et al. [32], Hebert et al. [33], Lau et al. [38], Denk et al. [34]
	hsa-miR-3163	Upregulated	Denk et al. [34]
NUP160	hsa-miR-1185-1-3p	Downregulated	Lau et al. [38]
	hsa-miR-126-5p	Downregulated	Cogswell et al. [32], Hebert et al. [35], Leidinger et al. [37], Denk et al. [34]
	hsa-miR-133b	Downregulated	Cogswell et al. [32], Hebert et al. [33], Denk et al. [34]
	hsa-miR-323b-3p	Upregulated	Leidinger et al. [37]

A summary of the miRNAs predicted to target FERMT2 and NUP160, for which alterations in expression have been reported in Alzheimer’s disease (AD; mainly downregulated, upregulated, or not altered; refer to the quoted references). MicroRNAs (miRNA, miR) for which the literature results are ambiguous are not mentioned in the table